Connecting biomedical data to help researchers prioritise biomarkers and drug targets
Biomedical research involves complex relationships among genes, compounds, diseases and patients. Selecting biomarkers and drug targets requires researchers to connect molecular biology, clinical evidence and scientific literature to understand these relationships.
D&A MedLabs is developing an AI platform that connects biomedical data in knowledge graphs. It is designed to help research teams explore biological relationships and prioritise biomarkers and drug targets for further investigation.
What stands out about D&A MedLabs
Reports identifying five repurposable drugs with mechanisms consistent with Alzheimer’s biology through biomedical evidence integration.
Get a curated pipeline of healthcare and life sciences startups aligned with your investment thesis.